Bpifrance backs LimFlow’s $33.5m series C round

The funding will be used to develop trials in the United States.

French medtech company LimFlow has this week announced the successful close of a series C round of funding worth €27m ($33.5m).

The round was led by Sofinnova Partners and featured returning investors Bpifrance, the French sovereign investment bank, and Singaporean fund Balestier.

See more from this Government Report: France


Supporting articles

Copyright Mawsonia Limited 2010. Please don't cut articles from www.globalgovernmentventuring.com or the PDF and redistribute by email or post to the web without written permission.

Most read

  1. News round up 23 April 2018

    April 23, 2018

  2. EU plans massive overhaul of funding services

    April 25, 2018

  3. DocuSign seals $629m IPO

    April 27, 2018

  4. Investors fork over $30m to Formlabs

    April 27, 2018

  5. Mubadala backs New York’s Phoenician Capital

    April 27, 2018